Plain-English translation of NCT07429071 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing Papilocare®, a vaginal gel made from natural ingredients, to see if it can help your body clear a persistent HPV infection and heal early cervical changes. Right now, women with these changes usually just wait and watch to see if the body clears the virus on its own, or they need surgery. The medication aims to offer a non-invasive option that might help your body fight the infection naturally.
Many women with HPV and early cervical changes face a long period of anxiety while waiting to see if their body clears the virus on its own, or they need invasive surgery. This trial exists because doctors need better, non-surgical treatment options to help women's bodies clear HPV and prevent these changes from getting worse.
You likely qualify if…
You likely don't qualify if…
You would be randomly assigned to either use the vaginal gel for 6 months or continue with standard watchful waiting. Either way, you'll return for a follow-up exam at 6 months that includes a colposcopy (a magnified view of your cervix), a small tissue sample, and vaginal swabs to check if the HPV has cleared. You'll also complete brief questionnaires before and after about your stress and anxiety levels, and if you're using the gel, you'll answer questions about how easy it was to use and how satisfied you are with the treatment.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
Denmark